Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients | Zendy

Nicholas Britt | Zendy; Emily Potter | Zendy; Nimish Patel | Zendy; Molly E. Steed | Zendy

Open Access

Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients

Author(s) -

Nicholas Britt,

Emily Potter,

Nimish Patel,

Molly E. Steed

Publication year - 2015

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/civ444

Subject(s) - medicine , daptomycin , linezolid , retrospective cohort study , poisson regression , cohort , vancomycin , cohort study , veterans affairs , staphylococcus aureus , population , environmental health , biology , bacteria , genetics

Vancomycin-resistant Enterococcus bloodstream infections (VRE-BSIs) are becoming increasingly common. Linezolid and daptomycin are the primary treatment options for VRE-BSI, but optimal treatment is unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research